BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND MUTYH, MYH, 4595, ENSG00000132781, hMYH, MGC4416, MYHbeta AND Treatment
22 results:

  • 1. Secondary (additional) findings from the 100,000 Genomes Project: Disease manifestation, health care outcomes, and costs of disclosure.
    Nolan J; Buchanan J; Taylor J; Almeida J; Bedenham T; Blair E; Broadgate S; Butler S; Cazeaux A; Craft J; Cranston T; Crawford G; Forrest J; Gabriel J; George E; Gillen D; Haeger A; Hastings Ward J; Hawkes L; Hodgkiss C; Hoffman J; Jones A; Karpe F; Kasperaviciute D; Kovacs E; Leigh S; Limb E; Lloyd-Jani A; Lopez J; Lucassen A; McFarlane C; O'Rourke AW; Pond E; Sherman C; Stewart H; Thomas E; Thomas S; Thomas T; Thomson K; Wakelin H; Walker S; Watson M; Williams E; Ormondroyd E
    Genet Med; 2024 Mar; 26(3):101051. PubMed ID: 38131308
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD).
    Incorvaia L; Badalamenti G; Novo G; Gori S; Cortesi L; Brando C; Cinieri S; Curigliano G; Ricciardi GR; Toss A; Chiari R; Berardi R; Ballatore Z; Bono M; Bazan Russo TD; Gristina V; Galvano A; Damerino G; Blasi L; Bazan V; Russo A
    ESMO Open; 2024 Jan; 9(1):102196. PubMed ID: 38118367
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A Randomized Trial Comparing the Effectiveness of Pre-test Genetic Counseling Using an Artificial Intelligence Automated Chatbot and Traditional In-person Genetic Counseling in Women Newly Diagnosed with breast cancer.
    Al-Hilli Z; Noss R; Dickard J; Wei W; Chichura A; Wu V; Renicker K; Pederson HJ; Eng C
    Ann Surg Oncol; 2023 Oct; 30(10):5990-5996. PubMed ID: 37567976
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Uncommon variants detected via hereditary cancer panel and suggestions for genetic counseling.
    Özdemir Z; Çevik E; Öksüzoğlu ÖBÇ; Doğan M; Ateş Ö; Esin E; Bilgetekin İ; Demirci U; Köseoğlu Ç; Topal A; Karadurmuş N; Erdem HB; Bahsi T
    Mutat Res; 2023; 827():111831. PubMed ID: 37453313
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Hereditary cancer Syndrome in a Family with Double Mutation in
    D'Elia G; Caliendo G; Passariello L; Albanese L; Makker J; Molinari AM; Vietri MT
    Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833355
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Strong Hereditary Predispositions to Colorectal cancer.
    Hryhorowicz S; Kaczmarek-Ryś M; Lis-Tanaś E; Porowski J; Szuman M; Grot N; Kryszczyńska A; Paszkowski J; Banasiewicz T; Pławski A
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553592
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Concurrent Pathogenic Variants of BRCA1, mutyh and CHEK2 in a Hereditary cancer Family.
    Agaoglu NB; Ng OH; Unal B; Dogan OA; Amanvermez U; Yildiz J; Doganay L; Ghazani AA; Rana HQ
    Cancer Genet; 2022 Nov; 268-269():128-136. PubMed ID: 36368126
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Integration of Universal Germline Genetic Testing for All New breast cancer Patients.
    Culver JO; Freiberg Y; Ricker C; Comeaux JG; Chang EY; Banerjee V; Sturgeon D; Solomon I; Kagey J; Dobre MG; Carey J; Carr A; Cho S; Lu J; Kang IM; Patel K; Terando A; Ye JC; Li M; Lerman C; Spicer D; Nelson M
    Ann Surg Oncol; 2023 Feb; 30(2):1017-1025. PubMed ID: 36161375
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Multi-Gene Mutation Profiling by Targeted Next-Generation Sequencing in Premenopausal breast cancer.
    Zografos E; Andrikopoulou A; Papatheodoridi AM; Kaparelou M; Bletsa G; Liontos M; Dimopoulos MA; Zagouri F
    Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 36011273
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Hereditary breast cancer and fertility preservation outcomes.
    Arab S; Tulandi T; Buckett W
    J Assist Reprod Genet; 2022 May; 39(5):1163-1168. PubMed ID: 35403930
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. 30 year experience of index case identification and outcomes of cascade testing in high-risk breast and colorectal cancer predisposition genes.
    Woodward ER; Green K; Burghel GJ; Bulman M; Clancy T; Lalloo F; Schlecht H; Wallace AJ; Evans DG
    Eur J Hum Genet; 2022 Apr; 30(4):413-419. PubMed ID: 34866136
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Germline and Somatic Mutations in Archived breast cancer Specimens of Different Subtypes].
    Abramov IS; Korneva YS; Shisterova OA; Ikonnikova AY; Emelyanova MA; Lisitsa TS; Krasnov GS; Nasedkina TV
    Mol Biol (Mosk); 2021; 55(3):412-421. PubMed ID: 34097676
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. New germline mutations in BRCA1, ATM, mutyh, and RAD51D genes in Tuvans early-onset breast cancer patients.
    Gervas P; Molokov A; Ivanova A; Panferova Y; Kiselev A; Chernyshova A; Pisareva L; Choynzonov E; Cherdyntseva N
    Exp Oncol; 2021 Mar; 43(1):52-55. PubMed ID: 33785725
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With breast cancer or Ovarian cancer, 2012-2019.
    Kurian AW; Ward KC; Abrahamse P; Bondarenko I; Hamilton AS; Deapen D; Morrow M; Berek JS; Hofer TP; Katz SJ
    J Clin Oncol; 2021 May; 39(15):1631-1640. PubMed ID: 33560870
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair-targeted therapies.
    Tlemsani C; Takahashi N; Pongor L; Rajapakse VN; Tyagi M; Wen X; Fasaye GA; Schmidt KT; Desai P; Kim C; Rajan A; Swift S; Sciuto L; Vilimas R; Webb S; Nichols S; Figg WD; Pommier Y; Calzone K; Steinberg SM; Wei JS; Guha U; Turner CE; Khan J; Thomas A
    Sci Transl Med; 2021 Jan; 13(578):. PubMed ID: 33504652
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Pathogenic Germline Mutations in DNA Repair Genes in Combination With cancer treatment Exposures and Risk of Subsequent Neoplasms Among Long-Term Survivors of Childhood cancer.
    Qin N; Wang Z; Liu Q; Song N; Wilson CL; Ehrhardt MJ; Shelton K; Easton J; Mulder H; Kennetz D; Edmonson MN; Rusch MC; Downing JR; Hudson MM; Nichols KE; Zhang J; Robison LL; Yasui Y
    J Clin Oncol; 2020 Aug; 38(24):2728-2740. PubMed ID: 32496904
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers.
    Nones K; Johnson J; Newell F; Patch AM; Thorne H; Kazakoff SH; de Luca XM; Parsons MT; Ferguson K; Reid LE; McCart Reed AE; Srihari S; Lakis V; Davidson AL; Mukhopadhyay P; Holmes O; Xu Q; Wood S; Leonard C; ; ; ; Beesley J; Harris JM; Barnes D; Degasperi A; Ragan MA; Spurdle AB; Khanna KK; Lakhani SR; Pearson JV; Nik-Zainal S; Chenevix-Trench G; Waddell N; Simpson PT
    Ann Oncol; 2019 Jul; 30(7):1071-1079. PubMed ID: 31090900
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Inherited DNA repair gene mutations detected by tumor next generation sequencing in urinary tract cancers.
    Gupta S; Greenberg S; Grimmett J; Gaston D; Agarwal N; Lowrance W; Schiffman J; Kohlmann W
    Fam Cancer; 2017 Oct; 16(4):545-550. PubMed ID: 28315974
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Adherence and discontinuation of oral hormonal therapy in patients with hormone receptor positive breast cancer.
    Ayres LR; Baldoni Ade O; Borges AP; Pereira LR
    Int J Clin Pharm; 2014 Feb; 36(1):45-54. PubMed ID: 23934310
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Hereditary genes and SNPs associated with breast cancer.
    Mahdi KM; Nassiri MR; Nasiri K
    Asian Pac J Cancer Prev; 2013; 14(6):3403-9. PubMed ID: 23886119
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.